Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...

It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but ...

AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...

AI is transforming drug discovery, but accurately predicting patient responses remains challenging. Considering the ongoing need to connect drugs with the right patients and rising drug costs, ...

In a recent Bloomberg Television interview, Demis Hassabis, CEO of DeepMind and Nobel laureate, revealed that AI could ...

The wide range of chromatographic techniques share one common aim: to separate a material into its components. A material, your sample, is dissolved in a solvent, called the mobile phase. This mixture ...

NEW HAVEN, CT / ACCESS Newswire / September 4, 2025 / Revalia Bio Inc., announced a 14.5M seed funding round to support their ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...

New draft guidelines suggest the FDA is open to exercising regulatory flexibility for non-opioid drugs being developed for chronic pain.